Detalhe da pesquisa
1.
Inflammation in acute myocardial infarction: the good, the bad and the ugly.
Eur Heart J
; 45(2): 89-103, 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587550
2.
How to hit the allergy target: A critical appraisal of intralymphatic immunotherapy with practical recommendations on ultrasound-guided injections.
Allergy
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712754
3.
Atypical and Typical Presentation of Erythema Nodosum: Clinical Differences in Treatment and Outcome.
Dermatology
; 240(2): 226-232, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185114
4.
Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
J Eur Acad Dermatol Venereol
; 38(4): 719-731, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084852
5.
Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice.
Clin Exp Allergy
; 53(5): 550-560, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629248
6.
Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
Allergy
; 78(6): 1605-1614, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36704937
7.
The next generation virus-like particle platform for the treatment of peanut allergy.
Allergy
; 78(7): 1980-1996, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883475
8.
Potential Cost Savings by Switching from Subcutaneous to Intralymphatic Insect Venom Immunotherapy.
Int Arch Allergy Immunol
; 184(10): 985-993, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467738
9.
Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.
Dermatology
; 239(5): 811-817, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369187
10.
Epitranscriptomics modifier pentostatin indirectly triggers Toll-like receptor 3 and can enhance immune infiltration in tumors.
Mol Ther
; 30(3): 1163-1170, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563676
11.
A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Allergy
; 77(1): 243-257, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496033
12.
The A to I editing landscape in melanoma and its relation to clinical outcome.
RNA Biol
; 19(1): 996-1006, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35993275
13.
Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia.
Immunity
; 37(6): 1050-1060, 2012 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177320
14.
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens.
J Allergy Clin Immunol
; 145(4): 1240-1253.e3, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31866435
15.
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
J Hepatol
; 72(5): 960-975, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954207
16.
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch.
Allergy
; 75(4): 862-871, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816097
17.
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI).
Allergy
; 75(4): 746-760, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774179
18.
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.
J Immunol
; 200(9): 3151-3159, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29592962
19.
Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.
J Allergy Clin Immunol
; 144(1): 193-203, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056187
20.
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses.
Allergy
; 74(3): 572-582, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30402930